Private Practice

Partner, Goldman Ismail Tomaselli Brennan & Baum LLP

Partner, Bartlit Beck Herman Palenchar & Scott LLP

Associate, Bartlit Beck Herman Palenchar & Scott LLP

Associate, Wiggin and Dana LLP

Education

Yale Law School (J.D.)

Yale University School of Medicine (M.D.)

University of California at Berkeley (B.A., Psychology)

Professional & Community Affiliations

Lecturer, Yale University

News

Bar & Court Admissions

State of California

State of Connecticut (inactive)

Photo of Kenneth F. Baum

Kenneth F. Baum

Partner / Santa Monica
f310.382.9974

“Kenneth Baum is a stand-out name” in “complex medical and scientific matters” with “strong trial advocacy skills to boot.” – The Legal 500

Ken brings a highly specialized set of skills to defending claims brought against drug and medical device manufacturers. A graduate of both Yale Law School and the Yale University School of Medicine, Ken is widely regarded by clients and his peers as one of the nation’s leading practitioners in the products liability arena. Clients reporting to The Legal 500 repeatedly single out Ken as a “very hardworking, very skilled trial lawyer,” and a key practitioner in products liability and mass tort defense.

With a unique ability to synthesize and convey complex scientific and medical issues, Ken leads national science and expert teams in high-profile products liability litigations, including Vioxx® (Merck), Sprint Fidelis® (Medtronic), Seroquel® (AstraZeneca), gadolinium contrast dye (Bayer), Fosamax® (Merck), Mirena® (Bayer), and Zostavax® (Merck). Clients turn to Ken to depose key expert and treating physician witnesses, and his depositions have repeatedly led to litigation-ending Daubert rulings. Ken also is a pillar of bellwether trial teams, crafting case strategies and witness examinations that have led to numerous trial victories and, ultimately, the dismissal of thousands of cases nationwide.

Of Note

Representative Litigation

Fosamax Litigation

National science and expert team member and trial counsel for Merck & Co., Inc. in litigation concerning Fosamax®, a prescription drug used for the treatment and prevention of osteoporosis and other bone disorders.

Mirena IUD Litigation

Leader of national science and expert team for Bayer HealthCare Pharmaceuticals Inc. in litigation concerning the Mirena® intrauterine device.

Zostavax Litigation

Counsel and national science and expert team member for Merck & Co., Inc. in litigation concerning Merck’s shingles vaccine, Zostavax®.

Opioid Litigation

National counsel for UCB, Inc. in litigation concerning UCB’s opioid products.

Vioxx Litigation

National science and expert team member and trial counsel for Merck & Co., Inc. in litigation concerning Vioxx®, a prescription anti-inflammatory medication.

Gadolinium Contrast Dye Litigation

Counsel and leader of national science and expert team for Bayer HealthCare Pharmaceuticals Inc. in litigation concerning Bayer’s gadolinium-based contrast agents used in magnetic resonance imaging.

Sprint Fidelis Litigation

National science and expert team member for Medtronic in litigation concerning Medtronic’s Sprint Fidelis® heart defibrillator leads.

Seroquel Litigation

Counsel and national science and expert team member for AstraZeneca Pharmaceuticals in litigation concerning the prescription drug, Seroquel®, which is used to treat certain mental health disorders.

Baycol Litigation

Counsel and national science and expert team member for Bayer Corp. in litigation concerning Baycol®, a prescription cholesterol-reducing medication.

Hormone Replacement Therapy Litigation

National science and expert team member for Wyeth, Inc. in litigation concerning the hormone replacement therapy prescription drugs Premarin® and Prempro®.

Publications

Ken Baum & Julie Cantor, Doctors Can Ease Suffering, Even in Executions, New York Times (2014)

Ken Baum, Jennifer Greenblatt & Julie Cantor, Assessing the Post-Riegel Landscape: The Effect of Sales Representatives’ Actions on Preemption Analysis, Drug, Device & Biotechnology IADC Committee Newsletter (2014)

Now on PBS: When Law and Ethics Collide – Why Physicians Participate in Executions (TV broadcast, July 14, 2006)

Talk of the Nation: Medical Ethics and Capital Punishment (NPR radio broadcast, Feb. 23, 2006)

Ken Baum, Independent Medical Examinations: An Expanding Source of Physician Liability, Annals of Internal Medicine 2005; 142:974-78

Julie Cantor & Ken Baum, The Limits of Conscientious Objection—May Pharmacists Refuse to Fill Prescriptions for Emergency Contraception?, New England Journal of Medicine 2004; 351:2008-12

Kenneth Baum, “To Comfort Always”: Physician Participation in Executions, 5 N.Y.U. J. Legis. & Pub. Pol'y 47 (2002)

Kenneth F. Baum, Golden Eggs: Towards the Rational Regulation of Oocyte Donation, 2001 BYU L. Rev. 107 (2001)